Cargando…
Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting
OBJECTIVES: To determine the influence of different buffers, pH and meropenem concentrations on the degradation rates of meropenem in aqueous solution during storage at 32°C, with the aim of developing a formulation suitable for 24-hour infusion in an ambulatory elastomeric device, compliant with th...
Autores principales: | Jamieson, Conor, Allwood, Michael Charles, Stonkute, Donata, Wallace, Andrew, Wilkinson, Alan-Shaun, Hills, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147560/ https://www.ncbi.nlm.nih.gov/pubmed/32296506 http://dx.doi.org/10.1136/ejhpharm-2018-001699 |
Ejemplares similares
-
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements
por: Allwood, Michael Charles, et al.
Publicado: (2020) -
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements
por: Jamieson, Conor, et al.
Publicado: (2022) -
P15 Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document
por: Sime, Fekade B., et al.
Publicado: (2022) -
Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020) -
Assessment of ceftolozane/tazobactam stability in elastomeric devices
and suitability for continuous infusion via outpatient parenteral antimicrobial
therapy
por: Jamieson, Conor, et al.
Publicado: (2021)